These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9230219)

  • 1. Enhanced degradation of I-kappaB alpha contributes to endogenous activation of NF-kappaB in Hs294T melanoma cells.
    Shattuck-Brandt RL; Richmond A
    Cancer Res; 1997 Jul; 57(14):3032-9. PubMed ID: 9230219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated constitutive IkappaB kinase activity and IkappaB-alpha phosphorylation in Hs294T melanoma cells lead to increased basal MGSA/GRO-alpha transcription.
    Devalaraja MN; Wang DZ; Ballard DW; Richmond A
    Cancer Res; 1999 Mar; 59(6):1372-7. PubMed ID: 10096573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MGSA/GRO transcription is differentially regulated in normal retinal pigment epithelial and melanoma cells.
    Shattuck RL; Wood LD; Jaffe GJ; Richmond A
    Mol Cell Biol; 1994 Jan; 14(1):791-802. PubMed ID: 8264646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells.
    Yang J; Richmond A
    Cancer Res; 2001 Jun; 61(12):4901-9. PubMed ID: 11406569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of NF-kappaB-dependent proinflammatory gene expression in human RPE cells by a proteasome inhibitor.
    Wang XC; Jobin C; Allen JB; Roberts WL; Jaffe GJ
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):477-86. PubMed ID: 9950608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma.
    Dong G; Chen Z; Kato T; Van Waes C
    Cancer Res; 1999 Jul; 59(14):3495-504. PubMed ID: 10416616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive and cytokine-induced expression of the melanoma growth stimulatory activity/GRO alpha gene requires both NF-kappa B and novel constitutive factors.
    Wood LD; Richmond A
    J Biol Chem; 1995 Dec; 270(51):30619-26. PubMed ID: 8530498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMGI(Y) and Sp1 in addition to NF-kappa B regulate transcription of the MGSA/GRO alpha gene.
    Wood LD; Farmer AA; Richmond A
    Nucleic Acids Res; 1995 Oct; 23(20):4210-9. PubMed ID: 7479086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of nuclear factor-kappa B in human metastatic melanomacells and the effect of oxidative stress.
    Meyskens FL; Buckmeier JA; McNulty SE; Tohidian NB
    Clin Cancer Res; 1999 May; 5(5):1197-202. PubMed ID: 10353757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Level of interleukin-8 expression by metastatic human melanoma cells directly correlates with constitutive NF-kappaB activity.
    Huang S; DeGuzman A; Bucana CD; Fidler IJ
    Cytokines Cell Mol Ther; 2000 Mar; 6(1):9-17. PubMed ID: 10976534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation and IkappaBalpha degradation in human glioma cells and in experimental brain inflammation.
    Ichiyama T; Zhao H; Catania A; Furukawa S; Lipton JM
    Exp Neurol; 1999 Jun; 157(2):359-65. PubMed ID: 10364447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCAAT displacement protein regulates nuclear factor-kappa beta-mediated chemokine transcription in melanoma cells.
    Ueda Y; Su Y; Richmond A
    Melanoma Res; 2007 Apr; 17(2):91-103. PubMed ID: 17496784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma cells.
    Dhawan P; Richmond A
    J Biol Chem; 2002 Mar; 277(10):7920-8. PubMed ID: 11773061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells.
    Jobin C; Haskill S; Mayer L; Panja A; Sartor RB
    J Immunol; 1997 Jan; 158(1):226-34. PubMed ID: 8977194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of constitutive and induced NF-kappaB activation in malignant melanoma cells by capsaicin modulates interleukin-8 production and cell proliferation.
    Patel PS; Varney ML; Dave BJ; Singh RK
    J Interferon Cytokine Res; 2002 Apr; 22(4):427-35. PubMed ID: 12034025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein tyrosine kinase inhibitors block tumor necrosis factor-induced activation of nuclear factor-kappaB, degradation of IkappaBalpha, nuclear translocation of p65, and subsequent gene expression.
    Natarajan K; Manna SK; Chaturvedi MM; Aggarwal BB
    Arch Biochem Biophys; 1998 Apr; 352(1):59-70. PubMed ID: 9521814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells.
    Krappmann D; Emmerich F; Kordes U; Scharschmidt E; Dörken B; Scheidereit C
    Oncogene; 1999 Jan; 18(4):943-53. PubMed ID: 10023670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of the HIV-1 LTR by specific NF-kappa B subunits in HSV-1-infected cells.
    Schafer SL; Hiscott J; Pitha PM
    Virology; 1996 Oct; 224(1):214-23. PubMed ID: 8862416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polaprezinc down-regulates proinflammatory cytokine-induced nuclear factor-kappaB activiation and interleukin-8 expression in gastric epithelial cells.
    Shimada T; Watanabe N; Ohtsuka Y; Endoh M; Kojima K; Hiraishi H; Terano A
    J Pharmacol Exp Ther; 1999 Oct; 291(1):345-52. PubMed ID: 10490923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent activation of nuclear factor-kappaB in cultured rat hepatic stellate cells involves the induction of potentially novel Rel-like factors and prolonged changes in the expression of IkappaB family proteins.
    Elsharkawy AM; Wright MC; Hay RT; Arthur MJ; Hughes T; Bahr MJ; Degitz K; Mann DA
    Hepatology; 1999 Sep; 30(3):761-9. PubMed ID: 10462383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.